Categories AlphaGraphs, Earnings, Other Industries
HR and payroll services drive Paychex profit higher
Paychex (PAYX) reported a 17% jump in earnings for the fourth quarter, helped by an increase in revenue from HR services and payroll services, besides lower income tax. The company’s stock inched up 0.29% in the premarket as its revenue exceeded the Street’s expectations.
With revenue increasing 9% to $871.1 million, the company’s earnings grew double-digits to $228.5 million or $0.63 per share. Adjusted EPS rose 13% to $0.61.
Human Resource Services (HRS) revenue increased 17% to $401 million, primarily driven by increases in client base. The company’s largest HRS revenue stream is Paychex HR Services, which includes administrative services and professional employer services. Rising demand for these resulted in double-digit growth in client worksite employees served as of May 31, 2018, compared to last year.
Payroll service revenue rose 3% to $452.4 million, riding on growth in revenue per check, which improved as a result of price increases. As of May 31, 2018, including the Lessor acquisition, Paychex served over 650,000 payroll clients.
Looking ahead into fiscal 2019, the company expects total revenue, including interest on funds held for clients, to increase in the range of 6-7% and adjusted EPS growth of about 11%. Payroll service revenue is expected to grow in the range of 2-3%, incorporating a full year of the lessor. HRS revenue is predicted to increase in the 15-20% range.
Shares of Paychex ended Tuesday’s regular trading session down 0.98% at $69 on the Nasdaq. The stock had been trading between $54.20 and $73.10 for the past 52 weeks.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company